泊馬度胺
外觀
![]() | |
臨床資料 | |
---|---|
商品名 | Pomalyst, Imnovid |
AHFS/Drugs.com | Monograph |
MedlinePlus | a613030 |
核准狀況 |
|
懷孕分級 | |
給藥途徑 | By mouth |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | 73% (at least)[8] |
血漿蛋白結合率 | 12–44% |
藥物代謝 | Liver (mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6) |
生物半衰期 | 7.5 hours |
排泄途徑 | Urine (73%), faeces (15%) |
識別資訊 | |
| |
CAS號 | 19171-19-8 ![]() |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.232.884 |
化學資訊 | |
化學式 | C13H11N3O4 |
摩爾質量 | 273.25 g·mol−1 |
3D模型(JSmol) | |
手性 | Racemic mixture |
| |
|
泊馬度胺(英語:Pomalidomide,商品名有Pomalyst、Imnovid)是一種含氮有機化合物,化學式為C13H11N3O4,可作為化療藥物[7],用於治療多發性骨髓瘤和AIDS相關的卡波西肉瘤[6]。
參考文獻
[編輯]- ^ Pomalidomide (Pomalyst) Use During Pregnancy. Drugs.com. 14 May 2020 [21 September 2020]. (原始內容存檔於25 January 2021).
- ^ Pomalidomide Medicianz/ Pomalimed/ Pomalidomide Medsurge (Medicianz Healthcare Pty Ltd). Therapeutic Goods Administration (TGA). 5 December 2022 [9 April 2023]. (原始內容存檔於18 March 2023).
- ^ Prescription medicines: registration of new chemical entities in Australia, 2014. Therapeutic Goods Administration (TGA). 21 June 2022 [10 April 2023]. (原始內容存檔於10 April 2023).
- ^ Product information.
- ^ Imnovid 1 mg hard capsules - Summary of Product Characteristics (SmPC). (emc). 16 June 2020 [21 September 2020]. (原始內容存檔於26 October 2020).
- ^ 6.0 6.1 Pomalyst- pomalidomide capsule. DailyMed. 7 December 2017 [21 September 2020]. (原始內容存檔於20 October 2020).
- ^ 7.0 7.1 Imnovid EPAR. European Medicines Agency (EMA). 17 September 2018 [21 September 2020]. (原始內容存檔於27 October 2020). Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ Imnovid 1 mg Hard Capsules. Summary of Product Characteristics. 5.2 Pharmacokinetic properties (PDF). Celgene Europe Ltd.: 22. [21 August 2016]. (原始內容存檔 (PDF)於27 June 2016).
- ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-15]. (原始內容存檔於2023-08-03) (巴西葡萄牙語).